BioHarvest Sciences Inc. BHST
Set alert
1.66 USD 0.00 0.00%
At close · Oct 30
1.66 0.00 0.00%
After hours · Oct 30, 4:00 PM ET
1.64 Day range 1.66
1.45 52-week range 9.76
- YTD
- -68.02%
- 1 year
- -82.99%
- Open
- 1.65
- Prev close
- 1.66
- Mkt cap
- 37.63M
- Vol
- 2.54K
- Avg vol
- 39.42K
- EPS
- -0.51
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.64
- High
- 1.66
- Forward P/E
- 0.00
- Beta
- 1.49
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 5.70
- 200-d avg
- 4.12
- 1y target
- 14.67
2Y chart
Events in this range
- Nov 25, 2024Earnings: -0.16; estimate -0.05; surprise -220%
Signals (73)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 29, 2026 | 2 days ago |
| SMA: Bullish | Oct 28, 2026 | 3 days ago |
| SMA: Bearish | Oct 20, 2026 | 1 week ago |
| SMA: Bullish | Oct 16, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 1, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 17, 2026 | 1 month ago |
| RSI: Oversold | Sep 16, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 31, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 28, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 3, 2026 | 2 months ago |
| MACD: Sell Signal | Jul 21, 2026 | 3 months ago |
| RSI: Oversold | Jul 21, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 2, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 24, 2026 | 4 months ago |
| RSI: Oversold | Jun 24, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 17, 2026 | 4 months ago |
| RSI: Oversold | Jun 4, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 1, 2026 | 5 months ago |
| MACD: Buy Signal | May 28, 2026 | 5 months ago |
| RSI: Oversold | May 8, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 30, 2026 | 6 months ago |
| MACD: Buy Signal | Mar 16, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 4, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 20, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 17, 2026 | 8 months ago |
| MACD: Buy Signal | Feb 9, 2026 | 8 months ago |
| MACD: Sell Signal | Feb 4, 2026 | 8 months ago |
| MACD: Buy Signal | Dec 16, 2025 | 10 months ago |
| MACD: Sell Signal | Dec 15, 2025 | 10 months ago |
| RSI: Oversold | Dec 12, 2025 | 10 months ago |
| MACD: Buy Signal | Nov 26, 2025 | 11 months ago |
| SMA: Bearish | Nov 13, 2025 | 11 months ago |
| SMA: Bullish | Nov 12, 2025 | 11 months ago |
| SMA: Bearish | Nov 7, 2025 | 11 months ago |
| SMA: Bearish | Oct 31, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 20, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 7, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 2, 2025 | 1 year ago |
| RSI: Overbought | Sep 23, 2025 | 1 year ago |
| MACD: Buy Signal | Sep 15, 2025 | 1 year ago |
| SMA: Bullish | Sep 12, 2025 | 1 year ago |
| SMA: Bearish | Sep 3, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 22, 2025 | 1 year ago |
| RSI: Overbought | Aug 8, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 24, 2025 | 1 year ago |
| MACD: Sell Signal | Jul 17, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 9, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 18, 2025 | 1 year ago |
| RSI: Overbought | Jun 12, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 3, 2025 | 1 year ago |
| SMA: Bullish | May 23, 2025 | 1 year ago |
| SMA: Bearish | May 21, 2025 | 1 year ago |
| MACD: Sell Signal | May 15, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 23, 2025 | 1 year ago |
| SMA: Bullish | Apr 21, 2025 | 1 year ago |
| SMA: Bearish | Apr 15, 2025 | 1 year ago |
| SMA: Bullish | Apr 14, 2025 | 1 year ago |
| SMA: Bearish | Apr 4, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 3, 2025 | 1 year ago |
| SMA: Bullish | Mar 14, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 14, 2025 | 1 year ago |
| MACD: Sell Signal | Mar 13, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 12, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 25, 2025 | 1 year ago |
| SMA: Bearish | Feb 24, 2025 | 1 year ago |
| SMA: Bullish | Feb 21, 2025 | 1 year ago |
| SMA: Bearish | Feb 19, 2025 | 1 year ago |
| SMA: Bullish | Feb 18, 2025 | 1 year ago |
| SMA: Bearish | Feb 11, 2025 | 1 year ago |
| SMA: Bullish | Feb 10, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 5, 2025 | 1 year ago |
| RSI: Oversold | Jan 28, 2025 | 1 year ago |
| RSI: Oversold | Jan 23, 2025 | 1 year ago |
Key statistics
- Market cap
- 105.70M
- Enterprise value
- 114.38M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 5.53
- Price / book
- 0.00
- EPS (TTM)
- -1.28
- Beta
- 1.49
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -84.84%
- Revenue (TTM)
- 19.13M
- Revenue growth
- 119.20%
- Free cash flow
- -5.96M
- Total cash
- 5.17M
- Total debt
- 10.39M
- Return on equity
- -5955.96%
- Shares outstanding
- 17.33M
- Short % of float
- 0.00%
- 50-day average
- 5.70
- 200-day average
- 4.12
Analyst view
Consensus: buy
Buy
Price target (mean) 14.67 +783.5% upside
Now 1.66
- Target (low)
- 12.00
- Target (mean)
- 14.67
- Target (high)
- 18.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy2
- Buy0
- Hold0
- Sell0
- Strong sell0
Next earnings
Consensus EPS estimate -0.14.
Financials — quick view
BHST Revenue — quarterly 8.84M
BHST Net income — quarterly -3.71M
BHST EPS — quarterly -0.17
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 25, 2024 | Sep 1, 2024 | -0.05 | -0.16 | -0.11 | -220.00% |
About BioHarvest Sciences Inc.
BioHarvest Sciences Inc. operates as a biotechnology company. The company operates through Nutraceuticals and Pharmaceuticals segments. It develops botanical synthesis platform technology to grow the ingredients in any plant enzymes or cells. The company is leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions in nutraceuticals and pharmaceuticals verticals. It also operates as a contract development and manufacturing operation services. In addition, the company offers wellness products. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red grapes. The company operates in Israel and the United States. BioHarvest Sciences Inc. is based in Vancouver, Canada.
- Country
- Canada
- Website
- bioharvest.com
News
- BioHarvest Sciences to Report Third Quarter 2026 Financial Results on November 12, 2026
- BioHarvest Sciences' Proprietary Olive Cell Composition Attains Commercial Readiness, Now Available For Licensing And Commercialization
- BioHarvest Sciences Board Authorizes Normal Course Issuer Bid To Repurchase Up To 5% Of Outstanding Common Shares
- Maxim Group Maintains Buy on BioHarvest Sciences, Lowers Price Target to $5
- Roth Capital Maintains Buy on BioHarvest Sciences, Lowers Price Target to $8
- Conference Call: BioHarvest Sciences Lowers FY2026 Sales Guidance from $42.000M-$48.000M to $37.000M-$40.000M vs $42.914M Est
- BioHarvest Sciences Revises FY26 CDMO Revenue Guidance to $4M-$5M from $4M-$6M; VINIA D2C Revenue Guidance to $33M-$35M from $38M-$42M
- BioHarvest Sciences Enters Agreement For A Rare, Endangered Fragrance Plant Cell Culture With A UAE-Based Customer; Sees $20M-$30M In 2027-28 Sales
- BioHarvest Sciences Receives $1.4M Grant Approval From Israel Innovation Authority
- BioHarvest Sciences Expands Its Joint Sweetener Development Program With Tate & Lyle To Include Multiple Plant-Based Sweetener Molecules
Your note
Sign in to keep a note on BHST — it syncs with the Stock Master app.